Go Pro

Westlake Chemical Partners (WLKP) Financials

Westlake Chemical Partners logo
$21.56 -0.11 (-0.53%)
Closing price 03:59 PM Eastern
Extended Trading
$21.50 -0.06 (-0.28%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Westlake Chemical Partners

Annual Income Statements for Westlake Chemical Partners

This table shows Westlake Chemical Partners' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
40 41 49 49 61 66 83 64 54 62 49
Consolidated Net Income / (Loss)
354 353 353 331 333 341 401 335 335 369 299
Net Income / (Loss) Continuing Operations
354 353 353 331 333 341 401 335 335 369 299
Total Pre-Tax Income
355 354 354 331 334 342 402 336 335 370 299
Total Operating Income
359 366 374 350 350 353 411 348 358 390 320
Total Gross Profit
383 391 404 377 379 379 442 377 387 419 348
Total Revenue
1,007 854 973 1,075 1,092 967 1,215 1,593 1,191 1,136 1,167
Operating Revenue
835 854 973 1,075 1,092 967 1,215 1,593 1,191 1,136 1,167
Total Cost of Revenue
624 462 569 698 712 588 773 1,216 803 717 819
Operating Cost of Revenue
624 462 569 698 712 588 773 1,216 803 717 819
Total Operating Expenses
24 25 29 28 29 26 31 30 30 28 28
Selling, General & Admin Expense
24 25 29 28 29 26 31 30 30 28 28
Total Other Income / (Expense), net
-4.81 -12 -20 -19 -17 -11 -8.75 -12 -22 -20 -20
Interest Expense
4.97 13 22 21 20 12 8.82 13 27 26 23
Other Income / (Expense), net
0.16 0.60 1.79 2.46 3.10 0.73 0.06 1.57 4.23 5.25 2.45
Income Tax Expense
0.67 1.04 1.28 0.02 0.73 0.56 0.55 1.02 0.81 0.84 0.55
Net Income / (Loss) Attributable to Noncontrolling Interest
314 312 304 281 272 275 319 271 280 307 250
Basic Earnings per Share
- - $1.43 $1.51 $1.77 $1.88 $2.34 $1.82 $1.54 $1.77 $1.38
Weighted Average Basic Shares Outstanding
27.06M 27.06M 28.39M 32.24M 34.49M 35.20M 35.21M 35.22M 35.22M 35.23M 35.25M
Diluted Earnings per Share
- - - - - - $2.34 $1.82 $1.54 $1.77 $1.38
Weighted Average Diluted Shares Outstanding
27.06M 27.06M 28.39M 32.24M 34.49M 35.20M 35.21M 35.22M 35.22M 35.23M 35.25M
Weighted Average Basic & Diluted Shares Outstanding
27.06M 27.06M 28.39M 32.24M 34.49M 35.20M 35.21M 35.22M 35.22M 35.23M 35.24M
Cash Dividends to Common per Share
$1.15 $1.29 $1.44 $1.61 $1.80 $1.89 $1.89 $1.89 $1.89 $1.89 $1.89

Quarterly Income Statements for Westlake Chemical Partners

This table shows Westlake Chemical Partners' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
14 15 14 18 15 4.95 15 15 15 14 14
Consolidated Net Income / (Loss)
87 90 88 104 87 42 86 86 84 82 82
Net Income / (Loss) Continuing Operations
87 90 88 104 87 42 86 86 84 82 82
Total Pre-Tax Income
87 90 88 104 88 42 86 86 84 82 83
Total Operating Income
93 95 94 110 92 47 91 92 90 87 87
Total Gross Profit
101 102 101 117 99 54 98 99 97 94 95
Total Revenue
297 285 284 277 290 238 297 309 323 306 297
Operating Revenue
297 285 284 277 290 238 297 309 323 306 297
Total Cost of Revenue
197 182 183 160 191 184 200 209 226 212 202
Operating Cost of Revenue
197 182 183 160 191 184 200 209 226 212 202
Total Operating Expenses
7.87 7.08 7.61 7.25 6.56 7.47 6.30 7.44 7.05 7.19 7.49
Selling, General & Admin Expense
7.87 7.08 7.61 7.25 6.56 7.47 6.30 7.44 7.05 7.19 7.49
Total Other Income / (Expense), net
-5.55 -5.25 -5.39 -5.37 -4.44 -4.19 -5.23 -5.72 -5.31 -4.74 -4.77
Interest Expense
6.63 6.58 6.65 6.70 5.77 5.54 5.91 5.95 5.51 5.09 5.12
Other Income / (Expense), net
1.08 1.33 1.26 1.33 1.34 1.35 0.68 0.22 0.20 0.35 0.35
Income Tax Expense
0.21 0.21 0.21 0.22 0.20 0.11 0.21 0.04 0.19 0.18 0.18
Net Income / (Loss) Attributable to Noncontrolling Interest
73 75 74 86 72 37 71 72 70 67 68
Basic Earnings per Share
$0.41 $0.42 $0.41 $0.51 $0.43 $0.14 $0.41 $0.42 $0.41 $0.40 $0.40
Weighted Average Basic Shares Outstanding
35.22M 35.23M 35.23M 35.24M 35.24M 35.24M 35.24M 35.25M 35.25M 35.25M 35.25M
Diluted Earnings per Share
$0.41 $0.42 $0.41 $0.51 $0.43 $0.14 $0.41 $0.42 $0.41 $0.40 $0.40
Weighted Average Diluted Shares Outstanding
35.22M 35.23M 35.23M 35.24M 35.24M 35.24M 35.24M 35.25M 35.25M 35.25M 35.25M
Weighted Average Basic & Diluted Shares Outstanding
35.22M 35.23M 35.23M 35.24M 35.23M 35.24M 35.24M 35.24M 35.24M 35.25M 35.25M

Annual Cash Flow Statements for Westlake Chemical Partners

This table details how cash moves in and out of Westlake Chemical Partners' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
36 -81 -62 -7.26 0.18 -2.77 -0.10 48 -6.16 -0.30 -14
Net Cash From Operating Activities
453 288 537 436 451 373 408 464 452 485 280
Net Cash From Continuing Operating Activities
453 288 537 436 451 373 408 464 452 485 280
Net Income / (Loss) Continuing Operations
354 353 353 331 333 341 401 335 335 369 299
Consolidated Net Income / (Loss)
354 353 353 331 333 341 401 335 335 369 299
Depreciation Expense
81 98 114 109 107 103 109 121 110 112 128
Non-Cash Adjustments To Reconcile Net Income
1.53 3.76 1.99 1.50 0.06 0.73 3.92 5.06 4.91 2.16 2.74
Changes in Operating Assets and Liabilities, net
16 -168 68 -4.76 11 -72 -106 2.77 2.26 1.78 -149
Net Cash From Investing Activities
-231 -299 -203 -52 -58 2.03 -64 -12 -76 -89 31
Net Cash From Continuing Investing Activities
-231 -299 -203 -52 -58 2.03 -64 -12 -76 -89 31
Purchase of Property, Plant & Equipment
-231 -300 -69 -40 -44 -37 -81 -54 -47 -49 -79
Purchase of Investments
- 0.00 -199 -384 -529 -349 -276 -320 -174 -40 -10
Sale and/or Maturity of Investments
- 0.00 63 372 515 388 293 362 145 0.00 120
Net Cash From Financing Activities
-186 -69 -396 -392 -393 -378 -344 -404 -382 -396 -326
Net Cash From Continuing Financing Activities
-186 -69 -396 -392 -393 -378 -344 -404 -382 -396 -326
Repayment of Debt
-135 -1.55 -286 0.00 -201 0.00 0.00 -32 -209 -219 -174
Payment of Dividends
-342 -280 -386 -395 -378 -378 -344 -404 -382 -396 -326
Issuance of Debt
292 212 165 3.65 124 0.00 0.00 32 209 219 174

Quarterly Cash Flow Statements for Westlake Chemical Partners

This table details how cash moves in and out of Westlake Chemical Partners' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-7.25 -2.86 10 -5.79 -1.89 -8.69 -13 1.36 6.33 0.02 5.03
Net Cash From Operating Activities
108 105 122 126 132 46 9.07 105 120 110 130
Net Cash From Continuing Operating Activities
108 105 122 126 132 46 9.07 105 120 110 130
Net Income / (Loss) Continuing Operations
87 90 88 104 87 42 86 86 84 82 82
Consolidated Net Income / (Loss)
87 90 88 104 87 42 86 86 84 82 82
Depreciation Expense
28 28 28 28 27 27 32 34 35 34 35
Non-Cash Adjustments To Reconcile Net Income
0.55 0.53 1.34 0.36 -0.06 0.24 0.28 1.85 0.37 0.13 2.23
Changes in Operating Assets and Liabilities, net
-8.24 -14 4.21 -6.50 18 -24 -109 -17 1.20 -5.89 10
Net Cash From Investing Activities
-23 -9.77 -10 -31 -38 14 36 0.35 -19 -19 -19
Net Cash From Continuing Investing Activities
-23 -9.77 -10 -31 -38 14 36 0.35 -19 -19 -19
Purchase of Property, Plant & Equipment
-13 -9.77 -10 -16 -13 -16 -24 -30 -8.83 -5.56 -12
Purchase of Investments
-10 - - -15 -25 0.00 - - -10 -13 -7.00
Net Cash From Financing Activities
-92 -98 -101 -101 -96 -69 -58 -104 -95 -92 -105
Net Cash From Continuing Financing Activities
-92 -98 -101 -101 -96 -69 -58 -104 -95 -92 -105
Repayment of Debt
-54 -54 -54 -55 -56 -54 -41 -40 -39 -41 -42
Payment of Dividends
-92 -98 -101 -101 -96 -69 -58 -104 -95 -92 -105
Issuance of Debt
54 54 54 55 56 54 41 40 39 41 42

Annual Balance Sheets for Westlake Chemical Partners

This table presents Westlake Chemical Partners' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,290 1,555 1,515 1,462 1,393 1,356 1,481 1,372 1,317 1,288 1,257
Total Current Assets
225 232 231 247 238 263 281 246 226 241 144
Cash & Equivalents
170 89 27 20 20 17 17 65 59 58 44
Short-Term Investments
- - - 149 - 123 - - 94 135 23
Accounts Receivable
52 139 62 74 53 119 149 111 68 44 73
Inventories, net
3.88 3.93 5.59 4.39 2.48 3.47 8.90 4.72 4.43 4.06 2.77
Prepaid Expenses
0.27 0.27 0.31 0.37 0.47 0.39 0.40 0.31 0.44 0.44 0.41
Plant, Property, & Equipment, net
1,020 1,222 1,196 1,148 1,103 1,051 1,044 990 944 904 886
Total Noncurrent Assets
45 101 88 67 52 43 156 136 147 143 227
Goodwill
5.81 5.81 5.81 5.81 5.81 5.81 5.81 5.81 5.81 5.81 5.81
Other Noncurrent Operating Assets
39 95 82 61 46 37 150 130 141 138 221
Total Liabilities & Shareholders' Equity
1,290 1,555 1,515 1,462 1,393 1,356 1,481 1,372 1,317 1,288 1,257
Total Liabilities
443 634 517 528 441 441 508 468 461 459 454
Total Current Liabilities
58 38 40 49 39 40 107 67 56 55 51
Accounts Payable
34 22 25 33 21 21 46 49 31 38 29
Accrued Expenses
23 16 16 16 18 19 61 18 25 17 22
Total Noncurrent Liabilities
385 596 476 479 402 402 401 401 404 403 403
Long-Term Debt
- - - - - - - 400 400 400 400
Noncurrent Deferred & Payable Income Tax Liabilities
1.39 1.74 2.22 1.66 1.65 1.54 1.53 1.66 1.63 1.55 1.55
Other Noncurrent Operating Liabilities
0.09 0.12 0.11 0.00 1.15 0.38 - 0.00 2.95 2.05 1.66
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
847 921 999 934 1,265 915 973 904 856 829 802
Total Preferred & Common Equity
97 103 220 216 590 313 294 292 280 276 259
Total Common Equity
97 103 220 216 590 277 294 292 280 276 259
Common Stock
97 102 220 216 590 313 294 292 280 276 259
Noncontrolling Interest
751 818 779 718 675 638 679 612 576 553 544

Quarterly Balance Sheets for Westlake Chemical Partners

This table presents Westlake Chemical Partners' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
1,343 1,336 1,342 1,295 1,288 1,295 1,371 1,307 1,272 1,236 1,217
Total Current Assets
232 221 231 224 232 242 225 157 131 149 158
Cash & Equivalents
105 59 66 56 66 60 50 37 38 44 49
Short-Term Investments
52 94 - - - 110 105 44 13 36 44
Accounts Receivable
70 63 76 69 66 67 68 73 76 65 61
Inventories, net
5.47 3.26 4.39 4.86 4.49 3.75 2.73 3.26 3.08 3.09 3.56
Prepaid Expenses
0.15 0.72 0.60 0.26 0.94 0.67 0.20 0.02 0.64 0.22 0.01
Plant, Property, & Equipment, net
977 963 959 927 913 909 903 902 903 872 859
Total Noncurrent Assets
133 152 151 144 143 144 243 249 238 215 201
Goodwill
5.81 5.81 5.81 5.81 5.81 5.81 5.81 5.81 5.81 5.81 5.81
Other Noncurrent Operating Assets
127 146 145 138 138 138 237 243 232 209 195
Total Liabilities & Shareholders' Equity
1,343 1,336 1,342 1,295 1,288 1,295 1,371 1,307 1,272 1,236 1,217
Total Liabilities
453 468 480 447 454 457 568 476 458 443 448
Total Current Liabilities
51 66 76 43 50 53 165 73 55 41 46
Accounts Payable
30 39 44 23 28 32 101 37 23 19 27
Accrued Expenses
21 27 31 20 22 21 63 36 32 22 19
Total Noncurrent Liabilities
401 401 405 404 404 404 403 403 403 403 402
Long-Term Debt
- 400 400 400 400 400 400 400 400 400 400
Noncurrent Deferred & Payable Income Tax Liabilities
1.64 1.64 1.66 1.66 1.68 1.57 1.57 1.58 1.52 1.52 1.49
Other Noncurrent Operating Liabilities
- - 3.31 2.41 2.55 2.35 2.18 1.86 1.98 1.33 1.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
890 868 861 848 835 838 803 831 813 792 769
Total Preferred & Common Equity
290 286 282 278 276 278 264 262 261 256 254
Total Common Equity
290 286 282 278 276 278 264 262 261 256 254
Common Stock
290 286 282 278 276 278 264 262 261 256 254
Noncontrolling Interest
600 582 579 570 559 560 539 569 553 536 516

Annual Metrics And Ratios for Westlake Chemical Partners

This table displays calculated financial ratios and metrics derived from Westlake Chemical Partners' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 35,245,879.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 35,245,879.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.38
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
359 365 373 350 349 352 410 347 357 390 319
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 26.60% 28.41% 31.70% 26.54%
Earnings before Interest and Taxes (EBIT)
359 367 376 352 353 354 411 349 362 396 322
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
441 465 490 461 461 457 520 470 472 508 450
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
226 0.30 354 552 260 510 229 463 493 456 221
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,062 1,427 1,446 1,243 1,332 1,174 1,355 1,239 1,103 1,036 1,134
Increase / (Decrease) in Invested Capital
133 365 19 -203 89 -157 181 -117 -136 -67 98
Book Value per Share
$3.58 $3.79 $6.83 $6.69 $16.77 $7.88 $8.35 $8.29 $7.95 $7.84 $7.34
Tangible Book Value per Share
$3.36 $3.58 $6.65 $6.51 $16.61 $7.72 $8.18 $8.12 $7.78 $7.67 $7.17
Total Capital
847 921 999 934 1,265 915 973 1,303 1,256 1,229 1,202
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 400 400 400 400
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 400 400 400 400
Net Debt
-170 -89 -27 -169 -20 -140 -17 335 247 207 332
Capital Expenditures (CapEx)
231 300 69 40 44 37 81 54 47 49 79
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1.97 105 164 30 180 83 157 114 17 -7.32 25
Debt-free Net Working Capital (DFNWC)
168 194 191 198 200 224 174 179 170 186 92
Net Working Capital (NWC)
168 194 191 198 200 224 174 179 170 186 92
Net Nonoperating Expense (NNE)
4.80 12 20 19 16 11 8.74 12 22 20 20
Net Nonoperating Obligations (NNO)
214 506 447 309 67 259 383 335 247 207 332
Total Depreciation and Amortization (D&A)
81 98 114 109 107 103 109 121 110 112 128
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.47 $0.00 $0.00 $0.00 $0.00 $1.88 $2.34 $1.82 $1.54 $1.77 $1.38
Adjusted Weighted Average Basic Shares Outstanding
27.06M 27.06M 32.24M 32.25M 35.19M 70.40M 70.43M 35.22M 35.23M 35.24M 35.25M
Adjusted Diluted Earnings per Share
$1.47 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.54 $1.77 $1.38
Adjusted Weighted Average Diluted Shares Outstanding
27.06M 27.06M 32.24M 32.25M 35.19M 70.40M 70.43M 35.22M 35.23M 35.24M 35.25M
Adjusted Basic & Diluted Earnings per Share
$1.47 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
27.06M 27.06M 28.39M 32.24M 34.49M 35.20M 35.21M 35.22M 35.22M 35.23M 35.24M
Normalized Net Operating Profit after Tax (NOPAT)
359 365 373 350 349 352 410 347 357 390 319
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Westlake Chemical Partners

This table displays calculated financial ratios and metrics derived from Westlake Chemical Partners' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - 35,245,879.00 35,245,879.00 35,245,879.00
DEI Adjusted Shares Outstanding
- - - - - - - - 35,245,879.00 35,245,879.00 35,245,879.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.41 0.40 0.40
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-18.96% -7.48% 7.57% -13.89% -2.43% -16.53% 4.56% 11.52% - 28.64% -0.01%
EBITDA Growth
-2.67% -0.94% 13.45% 20.21% -1.11% -39.71% 0.97% -9.38% - 61.58% -1.37%
EBIT Growth
-2.35% -2.57% 16.35% 26.86% -0.57% -50.28% -3.14% -16.94% - 81.25% -4.62%
NOPAT Growth
-2.60% -3.12% 16.31% 27.28% -0.85% -51.00% -2.56% -16.01% - 85.81% -4.28%
Net Income Growth
-4.61% -1.97% 16.96% 28.75% 0.38% -52.80% -2.53% -17.18% - 93.00% -4.00%
EPS Growth
-12.77% 0.00% 20.59% 37.84% 4.88% -66.67% 0.00% -17.65% - 185.71% -2.44%
Operating Cash Flow Growth
-12.16% -27.82% 23.70% 24.92% 23.03% -56.22% -92.56% -16.52% - 140.71% 1,331.45%
Free Cash Flow Firm Growth
7.81% -83.08% -79.25% 121.35% -30.56% 433.67% 181.06% -100.84% - -87.54% 47.68%
Invested Capital Growth
-10.96% 5.23% 4.90% -10.66% -6.05% -12.04% -1.56% 8.80% - 5.98% -6.45%
Revenue Q/Q Growth
-7.58% -4.24% -0.18% -2.52% 4.72% -18.08% 25.03% 3.96% - -5.38% -2.81%
EBITDA Q/Q Growth
5.58% 1.83% -0.99% 12.93% -13.14% -37.92% 65.81% 1.35% - -2.65% 1.21%
EBIT Q/Q Growth
7.29% 2.71% -1.61% 17.00% -15.90% -48.64% 91.66% 0.32% - -3.38% 0.85%
NOPAT Q/Q Growth
7.67% 2.47% -1.55% 17.19% -16.12% -49.37% 95.77% 1.01% - -3.54% 0.86%
Net Income Q/Q Growth
7.67% 2.97% -1.81% 18.26% -16.05% -51.58% 102.78% 0.49% - -3.09% 0.87%
EPS Q/Q Growth
10.81% 2.44% -2.38% 24.39% -15.69% -67.44% 192.86% 2.44% - -2.44% 0.00%
Operating Cash Flow Q/Q Growth
6.68% -2.88% 16.57% 3.43% 5.07% -65.44% -80.19% 1,060.16% - -8.46% 17.83%
Free Cash Flow Firm Q/Q Growth
120.59% -73.41% 9.12% 509.47% -33.04% 19.84% -42.53% -101.81% - 371.86% 581.04%
Invested Capital Q/Q Growth
-7.72% -0.43% -1.98% -8.62% -2.96% 1.21% 9.70% 0.98% - -2.03% -3.16%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
33.87% 35.89% 35.62% 42.22% 33.99% 22.76% 32.83% 32.19% - 30.67% 31.91%
EBITDA Margin
41.11% 43.71% 43.35% 50.23% 41.66% 31.57% 41.87% 40.81% - 39.66% 41.29%
Operating Margin
31.22% 33.41% 32.95% 39.60% 31.73% 19.61% 30.71% 29.78% - 28.32% 29.39%
EBIT Margin
31.59% 33.88% 33.39% 40.08% 32.19% 20.18% 30.93% 29.85% - 28.43% 29.50%
Profit (Net Income) Margin
29.29% 31.49% 30.98% 37.58% 30.13% 17.80% 28.88% 27.91% - 26.71% 27.72%
Tax Burden Percent
99.76% 99.77% 99.77% 99.79% 99.77% 99.75% 99.76% 99.95% - 99.78% 99.78%
Interest Burden Percent
92.94% 93.18% 92.99% 93.97% 93.82% 88.45% 93.57% 93.55% - 94.15% 94.16%
Effective Tax Rate
0.24% 0.23% 0.23% 0.21% 0.23% 0.25% 0.24% 0.05% - 0.22% 0.22%
Return on Invested Capital (ROIC)
31.68% 33.48% 34.21% 39.93% 33.62% 19.01% 29.11% 30.27% - 32.31% 32.52%
ROIC Less NNEP Spread (ROIC-NNEP)
29.78% 31.70% 32.35% 38.02% 31.67% 17.59% 27.51% 28.29% - 30.63% 31.00%
Return on Net Nonoperating Assets (RNNOA)
9.84% 10.70% 11.01% 12.62% 8.52% 6.28% 10.78% 9.91% - 10.84% 12.12%
Return on Equity (ROE)
41.52% 44.18% 45.23% 52.54% 42.14% 25.29% 39.89% 40.18% - 43.15% 44.65%
Cash Return on Invested Capital (CROIC)
42.07% 25.33% 27.37% 45.76% 42.67% 43.26% 30.79% 20.39% - 27.42% 38.55%
Operating Return on Assets (OROA)
27.98% 30.00% 30.23% 34.76% 28.07% 16.48% 26.26% 26.37% - 26.93% 28.86%
Return on Assets (ROA)
25.94% 27.88% 28.04% 32.59% 26.28% 14.54% 24.52% 24.66% - 25.30% 27.12%
Return on Common Equity (ROCE)
13.49% 14.45% 14.91% 17.32% 13.90% 8.31% 12.89% 13.10% - 14.08% 14.40%
Return on Equity Simple (ROE_SIMPLE)
0.00% 119.65% 125.20% 132.79% 0.00% 121.69% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
93 95 93 109 92 46 91 92 90 86 87
NOPAT Margin
31.15% 33.33% 32.87% 39.52% 31.65% 19.56% 30.63% 29.76% - 28.26% 29.32%
Net Nonoperating Expense Percent (NNEP)
1.91% 1.78% 1.86% 1.90% 1.95% 1.42% 1.60% 1.98% - 1.67% 1.52%
Return On Investment Capital (ROIC_SIMPLE)
7.37% - - - 7.47% 3.87% 7.39% 7.58% 7.45% 7.25% 7.45%
Cost of Revenue to Revenue
66.13% 64.11% 64.38% 57.78% 66.01% 77.24% 67.17% 67.81% - 69.33% 68.09%
SG&A Expenses to Revenue
2.65% 2.49% 2.68% 2.62% 2.26% 3.15% 2.12% 2.41% - 2.35% 2.52%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Operating Expenses to Revenue
2.65% 2.49% 2.68% 2.62% 2.26% 3.15% 2.12% 2.41% - 2.35% 2.52%
Earnings before Interest and Taxes (EBIT)
94 96 95 111 93 48 92 92 90 87 88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
122 124 123 139 121 75 124 126 125 121 123
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.46 2.81 2.88 2.84 2.90 3.08 2.97 2.84 - 3.04 3.09
Price to Tangible Book Value (P/TBV)
2.51 2.87 2.94 2.90 2.96 3.15 3.03 2.90 - 3.11 3.16
Price to Revenue (P/Rev)
0.58 0.67 0.67 0.69 0.70 0.75 0.71 0.65 - 0.63 0.64
Price to Earnings (P/E)
12.68 14.42 14.01 12.80 12.82 15.50 14.79 15.05 - 13.44 13.62
Dividend Yield
9.65% 8.49% 8.35% 8.41% 8.31% 8.17% 8.54% 8.98% - 8.54% 8.47%
Earnings Yield
7.89% 6.93% 7.14% 7.81% 7.80% 6.45% 6.76% 6.64% - 7.44% 7.34%
Enterprise Value to Invested Capital (EV/IC)
1.37 1.42 1.44 1.48 1.51 1.52 1.45 1.41 - 1.47 1.49
Enterprise Value to Revenue (EV/Rev)
1.27 1.45 1.42 1.38 1.37 1.47 1.51 1.45 - 1.32 1.30
Enterprise Value to EBITDA (EV/EBITDA)
3.20 3.60 3.48 3.10 3.07 3.49 3.63 3.68 - 3.29 3.25
Enterprise Value to EBIT (EV/EBIT)
4.18 4.72 4.53 3.99 3.94 4.60 4.84 5.04 - 4.53 4.50
Enterprise Value to NOPAT (EV/NOPAT)
4.24 4.79 4.60 4.05 4.00 4.68 4.92 5.11 - 4.55 4.53
Enterprise Value to Operating Cash Flow (EV/OCF)
3.34 4.12 3.88 3.43 3.22 3.75 5.32 5.61 - 4.74 3.45
Enterprise Value to Free Cash Flow (EV/FCFF)
3.07 5.76 5.40 3.05 3.42 3.30 4.67 7.22 - 5.52 3.74
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.47 0.47 0.48 0.48 0.48 0.50 0.48 0.49 - 0.50 0.52
Long-Term Debt to Equity
0.47 0.47 0.48 0.48 0.48 0.50 0.48 0.49 - 0.50 0.52
Financial Leverage
0.33 0.34 0.34 0.33 0.27 0.36 0.39 0.35 - 0.35 0.39
Leverage Ratio
1.53 1.52 1.54 1.55 1.55 1.61 1.56 1.55 - 1.63 1.58
Compound Leverage Factor
1.42 1.41 1.43 1.46 1.45 1.43 1.46 1.45 - 1.54 1.49
Debt to Total Capital
31.82% 32.03% 32.37% 32.30% 32.52% 33.23% 32.47% 32.95% - 33.53% 34.19%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Long-Term Debt to Total Capital
31.82% 32.03% 32.37% 32.30% 32.52% 33.23% 32.47% 32.95% - 33.53% 34.19%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital
45.89% 45.68% 45.27% 45.26% 45.01% 44.78% 46.21% 45.57% - 44.99% 44.11%
Common Equity to Total Capital
22.29% 22.29% 22.36% 22.44% 22.47% 21.99% 21.32% 21.49% - 21.48% 21.70%
Debt to EBITDA
0.85 0.85 0.82 0.79 0.79 0.87 0.87 0.90 - 0.81 0.81
Net Debt to EBITDA
0.52 0.73 0.69 0.45 0.41 0.54 0.69 0.78 - 0.64 0.62
Long-Term Debt to EBITDA
0.85 0.85 0.82 0.79 0.79 0.87 0.87 0.90 - 0.81 0.81
Debt to NOPAT
1.12 1.13 1.09 1.02 1.03 1.17 1.18 1.24 - 1.11 1.13
Net Debt to NOPAT
0.69 0.97 0.91 0.59 0.53 0.72 0.94 1.08 - 0.89 0.86
Long-Term Debt to NOPAT
1.12 1.13 1.09 1.02 1.03 1.17 1.18 1.24 - 1.11 1.13
Altman Z-Score
2.19 2.37 2.39 2.38 2.34 1.82 2.13 2.17 - 2.39 2.41
Noncontrolling Interest Sharing Ratio
67.51% 67.30% 67.02% 67.04% 67.01% 67.14% 67.68% 67.39% - 67.37% 67.75%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.02 5.21 4.68 4.53 4.35 1.37 2.15 2.37 - 3.65 3.44
Quick Ratio
3.93 2.90 2.67 4.45 4.27 1.35 2.10 2.31 - 3.57 3.36
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
228 36 39 237 159 190 109 -1.98 -8.71 24 161
Operating Cash Flow to CapEx
838.43% 1,069.94% 1,197.64% 810.95% 983.15% 286.92% 37.21% 354.91% - 1,983.41% 1,040.36%
Free Cash Flow to Firm to Interest Expense
34.43 5.41 5.84 35.35 27.48 34.32 18.49 -0.33 - 4.66 31.50
Operating Cash Flow to Interest Expense
16.24 15.89 18.33 18.82 22.95 8.27 1.54 17.70 - 21.67 25.37
Operating Cash Flow Less CapEx to Interest Expense
14.30 14.40 16.80 16.50 20.62 5.39 -2.59 12.71 - 20.58 22.93
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.89 0.89 0.91 0.87 0.87 0.82 0.85 0.88 - 0.95 0.98
Accounts Receivable Turnover
13.29 16.79 18.40 15.92 20.32 15.89 15.86 15.83 - 18.58 18.46
Inventory Turnover
175.65 151.89 204.13 177.30 168.89 189.12 189.64 229.63 - 290.84 249.10
Fixed Asset Turnover
1.23 1.23 1.27 1.22 1.23 1.19 1.21 1.25 - 1.39 1.40
Accounts Payable Turnover
19.89 29.21 23.56 18.96 20.54 11.51 22.81 28.50 - 14.07 26.86
Days Sales Outstanding (DSO)
27.47 21.74 19.84 22.93 17.97 22.97 23.02 23.05 - 19.65 19.78
Days Inventory Outstanding (DIO)
2.08 2.40 1.79 2.06 2.16 1.93 1.92 1.59 - 1.26 1.47
Days Payable Outstanding (DPO)
18.35 12.50 15.49 19.25 17.77 31.71 16.00 12.81 - 25.94 13.59
Cash Conversion Cycle (CCC)
11.20 11.65 6.13 5.74 2.36 -6.81 8.94 11.84 - -5.04 7.66
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,103 1,192 1,169 1,068 1,036 1,049 1,150 1,162 1,134 1,111 1,076
Invested Capital Turnover
1.02 1.00 1.04 1.01 1.06 0.97 0.95 1.02 - 1.14 1.11
Increase / (Decrease) in Invested Capital
-136 59 55 -127 -67 -144 -18 94 98 63 -74
Enterprise Value (EV)
1,511 1,696 1,688 1,580 1,560 1,598 1,666 1,641 - 1,634 1,607
Market Capitalization
688 782 796 790 800 814 778 740 - 779 785
Book Value per Share
$7.95 $7.90 $7.84 $7.88 $7.84 $7.51 $7.45 $7.40 $7.34 $7.27 $7.20
Tangible Book Value per Share
$7.78 $7.73 $7.67 $7.72 $7.67 $7.34 $7.28 $7.23 $7.17 $7.10 $7.03
Total Capital
1,256 1,248 1,235 1,237 1,229 1,203 1,231 1,213 1,202 1,192 1,169
Total Debt
400 400 400 400 400 400 400 400 400 400 400
Total Long-Term Debt
400 400 400 400 400 400 400 400 400 400 400
Net Debt
247 344 334 230 207 246 319 348 332 319 307
Capital Expenditures (CapEx)
13 9.77 10 16 13 16 24 30 8.83 5.56 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)
17 126 117 19 -7.32 -94 3.12 24 25 27 19
Debt-free Net Working Capital (DFNWC)
170 181 183 188 186 60 84 76 92 108 112
Net Working Capital (NWC)
170 181 183 188 186 60 84 76 92 108 112
Net Nonoperating Expense (NNE)
5.54 5.23 5.38 5.36 4.43 4.18 5.22 5.72 5.30 4.73 4.76
Net Nonoperating Obligations (NNO)
247 344 334 230 207 246 319 348 332 319 307
Total Depreciation and Amortization (D&A)
28 28 28 28 27 27 32 34 35 34 35
Debt-free, Cash-free Net Working Capital to Revenue
1.41% 10.75% 9.81% 1.62% -0.64% -8.62% 0.28% 2.15% - 2.22% 1.53%
Debt-free Net Working Capital to Revenue
14.27% 15.52% 15.37% 16.47% 16.34% 5.54% 7.59% 6.68% - 8.76% 9.05%
Net Working Capital to Revenue
14.27% 15.52% 15.37% 16.47% 16.34% 5.54% 7.59% 6.68% - 8.76% 9.05%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.41 $0.42 $0.41 $0.51 $0.43 $0.14 $0.41 $0.42 $0.41 $0.40 $0.40
Adjusted Weighted Average Basic Shares Outstanding
35.22M 35.23M 35.23M 35.24M 35.24M 35.24M 35.24M 35.25M 35.25M 35.25M 35.25M
Adjusted Diluted Earnings per Share
$0.41 $0.42 $0.41 $0.51 $0.43 $0.14 $0.41 $0.42 $0.41 $0.40 $0.40
Adjusted Weighted Average Diluted Shares Outstanding
35.22M 35.23M 35.23M 35.24M 35.24M 35.24M 35.24M 35.25M 35.25M 35.25M 35.25M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
35.22M 35.23M 35.23M 35.24M 35.23M 35.24M 35.24M 35.24M 35.24M 35.25M 35.25M
Normalized Net Operating Profit after Tax (NOPAT)
93 95 93 109 92 46 91 92 90 86 87
Normalized NOPAT Margin
31.15% 33.33% 32.87% 39.52% 31.65% 19.56% 30.63% 29.76% - 28.26% 29.32%
Pre Tax Income Margin
29.35% 31.56% 31.05% 37.66% 30.20% 17.85% 28.94% 27.92% - 26.77% 27.78%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
14.16 14.65 14.27 16.57 16.18 8.66 15.56 15.50 - 17.09 17.12
NOPAT to Interest Expense
13.96 14.42 14.04 16.34 15.91 8.40 15.41 15.46 - 16.99 17.02
EBIT Less CapEx to Interest Expense
12.22 13.17 12.74 14.25 13.84 5.78 11.43 10.52 - 16.00 14.69
NOPAT Less CapEx to Interest Expense
12.03 12.93 12.51 14.02 13.57 5.51 11.28 10.47 - 15.89 14.58
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
114.22% 112.55% 109.64% 106.42% 107.36% 114.10% 101.21% 108.17% - 103.22% 118.51%
Augmented Payout Ratio
114.22% 112.55% 109.64% 106.42% 107.36% 114.10% 101.21% 108.17% - 103.22% 118.51%

Financials Breakdown Chart

Key Financial Trends

Westlake Chemical Partners’ recent results show resilient cash generation, but relatively flat operating performance and a capital-allocation model heavily centered on distributions. Revenue in Q2 2026 was $297.1 million, essentially unchanged from Q2 2025 and below the $448.8 million reported in Q2 2022. The company’s earnings have been more stable than its revenue: Q2 2026 consolidated net income was $82.4 million, while net income attributable to common shareholders was $14.2 million, or $0.40 per diluted share.

Profitability has generally remained strong, although margins have moderated from earlier periods. Q2 2026 gross profit was $94.8 million, compared with $97.5 million in Q2 2025 and $101.2 million in Q2 2024. Gross margin was approximately 31.9% in Q2 2026, down from 32.8% in Q2 2025. Operating income also declined 4.3% year over year to $87.3 million as selling, general and administrative expenses increased to $7.5 million.

Cash flow remains the strongest part of the financial profile. Operating cash flow rose to $129.8 million in Q2 2026 from $110.2 million in Q1 2026 and only $9.1 million in Q2 2025. The prior-year comparison was affected by a $109.5 million use of operating working capital, making the year-over-year increase appear unusually large. Depreciation remains substantial at $35.0 million in Q2 2026, meaning reported cash flow benefits materially from noncash expenses.

The balance sheet provides considerable short-term liquidity. At June 30, 2026, Westlake held $49.3 million of cash and $43.6 million of short-term investments, compared with combined cash and short-term investments of $80.5 million at June 30, 2025. Current assets of $157.5 million exceeded current liabilities of $45.8 million by a wide margin. However, long-term debt has remained near $399.7 million for several years, as debt repayments have generally been offset by new debt issuance.

Investors should also note the partnership’s distribution structure. Westlake paid $105.3 million of dividends in Q2 2026, substantially more than the $14.2 million attributable to common shareholders, although operating cash flow covered the payment during the quarter. The balance sheet includes $515.7 million of noncontrolling interest versus $253.7 million of common equity, so consolidated results do not flow entirely to WLKP common shareholders.

  • Strong operating cash flow: Q2 2026 operating cash flow of $129.8 million exceeded net income by a wide margin and covered capital expenditures of $12.5 million and dividend payments of $105.3 million.
  • Improved liquidity: Cash and short-term investments increased to approximately $92.9 million at the end of Q2 2026 from $80.5 million a year earlier.
  • Stable common-share earnings: Diluted EPS has remained near $0.40-$0.43 in recent quarters despite fluctuations in revenue and consolidated earnings.
  • Low current-liability burden: Current assets of $157.5 million were more than three times current liabilities of $45.8 million at June 30, 2026.
  • Consistent distribution focus: Quarterly cash dividends have generally been around $90 million to $105 million, supporting income-oriented investors but leaving less cash for reinvestment.
  • Stable interest expense: Quarterly interest expense has mostly remained between roughly $5 million and $6 million since 2024, suggesting limited near-term changes in the company’s debt cost.
  • Working-capital volatility: Changes in operating assets and liabilities have ranged from a $109.5 million use of cash in Q2 2025 to a $10.2 million source in Q2 2026, making individual-quarter cash flow comparisons less reliable.
  • Revenue remains below 2022 levels: Q2 2026 revenue of $297.1 million was approximately 34% below the $448.8 million reported in Q2 2022.
  • Recent margin pressure: Q2 2026 gross profit and operating income both declined year over year, while gross margin fell to approximately 31.9% from 32.8% in Q2 2025.
  • Debt has not meaningfully declined: Long-term debt remained approximately $399.7 million, with repayments largely matched by new borrowings. Continued large distributions may limit the pace of deleveraging.

Overall, WLKP’s statements depict a mature, cash-generative partnership with attractive liquidity and dependable distributions, but limited revenue growth and little progress reducing long-term debt. Investors should focus on whether operating cash flow continues to cover distributions and capital spending without relying on additional borrowing, while also accounting for the significant portion of consolidated earnings attributable to noncontrolling interests.

09/10/26 05:24 PM ETAI Generated. May Contain Errors.

Westlake Chemical Partners Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Westlake Chemical Partners' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

In the past 10 years, Westlake Chemical Partners' net income has ranged from $298.58 million in 2025 to $401.39 million in 2021, and is currently $298.58 million as of their latest financial filing in 2025. See where experts think Westlake Chemical Partners is headed by visiting Westlake Chemical Partners' forecast page.

Westlake Chemical Partners' total operating income in 2025 was $319.58 million, based on the following breakdown:
  • Total Gross Profit: $347.85 million
  • Total Operating Expenses: $28.27 million

Over the last 10 years, Westlake Chemical Partners' total revenue changed from $1.01 billion in 2015 to $1.17 billion in 2025, a change of 15.8%.

Westlake Chemical Partners' total liabilities were at $454.18 million at the end of 2025, a 1.0% decrease from 2024, and a 2.5% increase since 2015.

In the past 10 years, Westlake Chemical Partners' cash and equivalents has ranged from $17.06 million in 2021 to $169.56 million in 2015, and is currently $44.27 million as of their latest financial filing in 2025.

Over the last 10 years, Westlake Chemical Partners' book value per share changed from 3.58 in 2015 to 7.34 in 2025, a change of 105.0%.



Financial statements for NYSE:WLKP last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners